Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
SunCast
Nico Johnson
The Chain: Protein Engineering Podcast
Cambridge Healthtech Institute
Biophilic Solutions: Nature Has the Answers
Serenbe Media Network
The Veterinary Roundtable
The Veterinary Roundtable
Sci Fi x Horror
duane Old Time Radio
The Dr. Gabrielle Lyon Show
Dr. Gabrielle Lyon
Bench Boost by Inorganic Ventures
Inorganic Ventures
Heliox: Where Evidence Meets Empathy 🇨🇦
by SC Zoomers
Room to Think
Lyssia Katan
Come explore the paranormal files as we delve into the unexplained. The paranormal podcast.
Matt Harvey | Amanda Harvey Paranormal Experts
Referential
Dr. Khaliden Nas
Radiowissen
Bayerischer Rundfunk
The Long Run with Luke Timmerman
Timmerman Report
Sasquatch Experience
Anomalis Entertainment, LLC
Paranormal UK Radio Network
Paranormal UK Radio Network
The Science of Personality Podcast
Hogan Assessments
Real Science Exchange-Dairy
Balchem Animal Nutrition & Health
All Access DNA
allaccessdna
Auditory Anthology
Keith Conrad / Darren Marlar
Therapist Uncensored Podcast
Sue Marriott LCSW, CGP & Ann Kelley PhD
Command and Control
Peter Roberts
Qiological Podcast
Michael Max
پادکست مهرانگیز
reza amir
Historical Travel Stories💕旅行の歷史故事
Lawrence An
Environment Daily
Ground Report
Meteorology Matters
Rob Jones
Il Risveglio del Sogno Podcast
Michele Battuello
NEU DENKEN
Mission Wertvoll
Science Fictions
Tom Chivers and Stuart Ritchie
Public Health Insight
PHI Media
The Shiver Show
Time Warp Studios
Weather Wisdom
Dave Epstein
The Incubator
Ben Courchia & Daphna Yasova Barbeau
תל אביב 360 – ערוץ הפודקסטים של אוניברסיטת תל אביב
Tel Aviv University
The Road of Shadows
Mark R. Healy
Reef in Focus
Great Barrier Reef Marine Park Authority
Science
Cambridge Healthtech Institute
July 14, 2026 | Most ADCs today lean on the same Topo-1 payloads—and resistance is catching up. Jack Elands, Ph.D., founder and CEO of Adcytherix, speaks with host Rakesh Dixit, Ph.D. about what “next-generation ADCs” sh...
At this year’s PEGS Boston, industry experts gathered on a panel to explore how AI and machine learning are deployed in biologics R&D today. Moderated by Peter M. Tessier, Ph.D., Albert M. Mattocks professor of pharmaceu...
May 12, 2026 | When it comes to drug discovery, either you find a rare, clean target and everything clicks, or you spend a decade chasing biology that refuses to cooperate. Daniel Chen, M.D., Ph.D., founder and CEO of Sy...
How is BindCraft, the automated pipeline for de novo protein binder design, changing the protein design industry? Martin Pacesa, assistant professor of pharmacology at the University of Zurich, joins The Chain to discuss...
T cell and immune cell engagement is gaining traction, but what makes it different from other therapies? Patrick Baeuerle, Ph.D., chief scientific advisor at Cullinan Therapeutics, and Jeffrey Miller, M.D., deputy direct...
During last year’s PEGS Europe, industry experts gathered on a panel to discuss the future of biologic therapeutics. The panel kicked off with a presentation on 50 years of monoclonals, from hybridomas to next-gen antibo...
How has immunotherapy evolved in the last decade? In this episode of The Chain, Laszlo Radvanyi, professor of immunology at the University of Toronto, discusses his years-long research on cancer immunotherapy, including ...
December 13, 2025 | What is next for immunogenicity? In this episode of The Chain, Vibha Jawa, chief scientific officer at EpiVax, provides her thoughts and insights on BiTE molecules, pegylated molecules, and other biol...
November 11, 2025 | What is the next modality to focus on in the next 10 years? For Bahija Jallal, CEO of Immunocore, it would be T-cell engagers. In this episode of The Chain, host Rakesh Dixit speaks with Jallal on the...
As drug development pushes into more complex antibody formats, the big question is: how do you really assess developability? In this episode, host Nimish Gera speaks with Shamit Shrivastava, Ph.D., founder and CEO of Apo...
September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and au...
August 12, 2025 | Diagonal Therapeutics founder and CEO Alexey Lugovskoy discusses the key lessons learned over his illustrious career, starting from his childhood in the Soviet Union to founding his own company, Diagona...
July 15, 2025 | Are licensing fees required or gatekeeping? In this episode of The Chain, host Nimish Gera, vice president of Biologics at Mythic Therapeutics, and Ian Wilkinson, CEO of Gamma Proteins, discuss accessing ...
June 10, 2025 | In this bonus episode of The Chain, Daniel Chen, MD, PhD, founder and CEO of Synthetic Design Lab, returns for the Science Commune segment and speaks with Keith Flaherty, MD, FAACR, professor of Medicine ...
June 10, 2025 | This episode of The Chain features a panel discussion from May’s PEGS Boston. Moderated by Peter Tessier, Albert M. Mattocks professor of Pharmaceutical Sciences and Chemical Engineering at the University...
In this episode of The Chain, host Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC, talks with Pamela Barney, former associate director of HR, AbbVie, about her career within biotech/pharma organizations and some key les...
In this episode of The Chain, host Brandon DeKosky, associate professor, speaks with MIT colleague Jessica Stark, Underwood-Prescott career development professor, about glycans and why they are important in cancer resear...
March 11, 2025 | In this episode of The Chain, host Andrew Buchanan, principal scientist at AstraZeneca, and Andreas Plückthun, professor and head of biochemistry at the University of Zurich, discuss AI/ML technologies i...
February 21, 2025 | This episode marks the 50th anniversary of one of the most influential papers in biomedical science—the 1975 Milstein and Köhler paper on hybridoma technology, which paved the way for monoclonal antib...
In this episode of The Chain, host Andrew Bradbury, CSO of Specifica, an IQVIA business, speaks with Randolph Lopez, CTO and co-founder of A-Alpha Bio, about how A-Alpha Bio is changing the game of protein-protein intera...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.